Premium
EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL
Author(s) -
Schuster S. J.,
Dickinson M.,
Dreyling M.,
MartinezLopez J.,
Kolstad A.,
Butler J.,
Ghosh M.,
Popplewell L.,
Chavez J. C.,
Bachy E.,
Kato K.,
Harigae H.,
Kersten M. José,
Andreadis C.,
Riedell P. A.,
Abdelhady A.,
Zia A.,
Morisse M. C.,
Fowler N. H.,
Thieblemont C.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.85_2879
Subject(s) - medicine , clinical endpoint , refractory (planetary science) , gastroenterology , follicular lymphoma , surgery , phases of clinical research , lymphoma , clinical trial , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom